Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.45
N/A
Last update: Oct 19, 4:00 PM
$9.45
N/A
MeiraGTx Holdings PLC (MGTX) Stock Price, Quote, News & History
MGTXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of MeiraGTx Holdings (NASDAQ:MGTX) through any online brokerage.
Other companies in MeiraGTx Holdings’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
MeiraGTx Holdings has a consensus price target of $22.67.
The stock price for MeiraGTx Holdings (NASDAQ: MGTX) is $9.45 last updated October 19, 2026 at 4:00 PM EDT.
There are no upcoming dividends for MeiraGTx Holdings.
MeiraGTx Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for MeiraGTx Holdings.
MeiraGTx Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
